Inovio: Time To Think About 2020 [Seeking Alpha]
AstraZeneca PLC - American Depositary Shares (AZN)
Last astrazeneca plc - american depositary shares earnings: 2/5 04:00 pm
Check Earnings Report
US:NYSE Investor Relations:
astrazeneca.com/investor-relations.html
Company Research
Source: Seeking Alpha
Summary Inovio has developed a broad array of vaccines that appear to work for both infections like Hepatitis B and for some cancers. Its price is historically low because the time to reach FDA-approvable data has been repeatedly extended. Its closing price on July 10, 2018, was $4.44, despite an average target price of $11.00 per share from the analysts covering the stock. In 2020, data from the Phase 3 trial of VGX-3100 for HPV-related cervical dysplasia should be available. First revenue is possible (assuming FDA approval) in 2021. While those dates may seem impossibly far off for short-term investors, they are just around the corner for myself and other long-term investors. Inovio's technology is based on DNA-based vaccines that offer significant advantages over older types of vaccines, including the capability of treating a broader range of diseases. INO data by YCharts VGX-3100 is the main catalyst VGX-3100 is an anti-HPV ( human papillomavirus ) va
Show less
Read more
Impact Snapshot
Event Time:
AZN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AZN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AZN alerts
High impacting AstraZeneca PLC - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
AZN
News
- Pharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates [Yahoo! Finance]Yahoo! Finance
- AstraZeneca: Strong In A Weak Market [Seeking Alpha]Seeking Alpha
- Regenerative Medicine Market Size Expected to Reach USD 154.05 Bn by 2033 [Yahoo! Finance]Yahoo! Finance
- Fusion (FUSN) to Report Q1 Earnings: Here's What to Expect [Yahoo! Finance]Yahoo! Finance
- Borderline Personality Disorder (BPD) Global Clinical Trials Review 2024: Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End-Point Status [Yahoo! Finance]Yahoo! Finance
AZN
Sec Filings
- 4/25/24 - Form 6-K
- 4/11/24 - Form 6-K
- 4/11/24 - Form 6-K
- AZN's page on the SEC website